98 related articles for article (PubMed ID: 2583867)
1. Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cells.
Dierks-Ventling C; Knesel J; Nagamine Y; Hemmings BA; Pehling G; Fischer F; Fabbro D
Int J Cancer; 1989 Nov; 44(5):865-70. PubMed ID: 2583867
[TBL] [Abstract][Full Text] [Related]
2. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
Rondeau E; Guidet B; Lacave R; Bens M; Sraer J; Nagamine Y; Ardaillou R; Sraer JD
Biochim Biophys Acta; 1990 Nov; 1055(2):165-72. PubMed ID: 2122915
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
Ziegler A; Knesel J; Fabbro D; Nagamine Y
J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
[TBL] [Abstract][Full Text] [Related]
4. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C.
Nanbu R; Montero L; D'Orazio D; Nagamine Y
Eur J Biochem; 1997 Jul; 247(1):169-74. PubMed ID: 9249023
[TBL] [Abstract][Full Text] [Related]
5. PMA and staurosporine affect expression of the PCK gene in LLC-PK1-F+ cells.
Liu W; Feifel E; Holcomb T; Liu X; Spitaler N; Gstraunthaler G; Curthoys NP
Am J Physiol; 1998 Sep; 275(3):F361-9. PubMed ID: 9729508
[TBL] [Abstract][Full Text] [Related]
6. Urokinase synthesis and binding by glomerular epithelial cells in culture.
Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
[TBL] [Abstract][Full Text] [Related]
7. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells.
Hofstetter P; Kikinis Z; Altus MS; Pearson D; Nagamine Y
Mol Cell Biol; 1987 Dec; 7(12):4535-41. PubMed ID: 2830499
[TBL] [Abstract][Full Text] [Related]
8. Modulation of synovial fibroblast plasminogen activator and plasminogen activator inhibitor production by protein kinase C.
Uhl J; Newton RC; Gross JL; Rommi W; Mochan E
Biochim Biophys Acta; 1991 Nov; 1097(4):283-8. PubMed ID: 1742333
[TBL] [Abstract][Full Text] [Related]
9. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.
Ziegler A; Hagmann J; Kiefer B; Nagamine Y
J Biol Chem; 1990 Dec; 265(34):21194-201. PubMed ID: 1701176
[TBL] [Abstract][Full Text] [Related]
10. Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones.
Young MR; Young ME; Lozano Y; Coogan M; Bagash JM
Int J Cancer; 1991 Aug; 49(1):150-5. PubMed ID: 1651907
[TBL] [Abstract][Full Text] [Related]
11. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils.
Politis I; Zavizjon B; Cheli F; Baldi A
J Dairy Res; 2002 May; 69(2):195-204. PubMed ID: 12222798
[TBL] [Abstract][Full Text] [Related]
12. Dual regulation of alkaline phosphatase activity by calcitonin in porcine kidney cells.
Miyamoto K; Horita T; Waki Y; Suzuki R; Yamamoto S; Moritani S
Biol Pharm Bull; 1997 Dec; 20(12):1300-2. PubMed ID: 9448108
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C synergistically stimulates tumor necrosis factor-alpha-induced secretion of urokinase-type plasminogen activator in human dental pulp cells.
Hashizume H; Kamio N; Nakao S; Matsushima K; Sugiya H
J Physiol Sci; 2008 Feb; 58(1):83-6. PubMed ID: 18177545
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine.
Ritchie AJ; Johnson DR; Ewenstein BM; Pober JS
J Immunol; 1991 May; 146(9):3056-62. PubMed ID: 1707932
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
Kole KL; Gyetko MR; Simpson RU; Sitrin RG
Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cAMP-mediated gene induction: examination of renal epithelial cell mutants affected in the catalytic subunit of the cAMP-dependent protein kinase.
Pearson D; Nigg EA; Nagamine Y; Jans DA; Hemmings BA
Exp Cell Res; 1991 Jan; 192(1):315-8. PubMed ID: 1898592
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin induces 25-hydroxyvitamin D3 1alpha-hydroxylase mRNA expression via protein kinase C pathway in LLC-PK1 cells.
Yoshida N; Yoshida T; Nakamura A; Monkawa T; Hayashi M; Saruta T
J Am Soc Nephrol; 1999 Dec; 10(12):2474-9. PubMed ID: 10589684
[TBL] [Abstract][Full Text] [Related]
19. jun-N-terminal kinase regulates thrombin-induced PAI-1 gene expression in proximal tubular epithelial cells.
Pontrelli P; Ranieri E; Ursi M; Ghosh-Choudhury G; Gesualdo L; Paolo Schena F; Grandaliano G
Kidney Int; 2004 Jun; 65(6):2249-61. PubMed ID: 15149338
[TBL] [Abstract][Full Text] [Related]
20. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y
J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
